Venetoclax Effectiveness, Safety, and Treatment Patterns in Chronic Lymphocytic Leukemia Patients: Results from the CLL Collaborative Study of Real-World Evidence (CORE)

被引：0
|
作者：
Zheng, Dandan
Sail, Kavita
Roeker, Lindsey E.
Manzoor, Beenish S.
Tuncer, Hande H.
Allan, John N.
Ujjani, Chaitra S.
Barr, Paul M.
Brown, Jennifer R.
Eyre, Toby A.
Skarbnik, Alan
Bannerji, Rajat
Eichhorst, Barbara
Brander, Danielle M.
Sharmokh, Simon
Jiang, Daniel Dingfeng
Pena, German
Kamalakar, Rajesh
Emechebe, Nnadozie
Pivneva, Irina
Burne, Rebecca
Guerin, Annie
Davids, Matthew S.
Mato, Anthony
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-134676
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：6
相关论文
共 50 条
  • [21] Real-World Patterns of MRD Testing and Impact on Treatment for Chronic Lymphocytic Leukemia Patients
    Bacchus, Melissa
    Singh-Bulkan, Nivita
    Littleford, Hana E.
    Kim, Joseph
    Martin, Richard L.
    Lacoste, Alix M. B.
    Brimble, Elise
    O'Brien, Conner
    Saltzman, Larry A.
    Greenberger, Lee M.
    Nottke, Amanda
    BLOOD, 2023, 142
  • [22] Real-world treatment patterns and health care resource utilization (HRU) among patients with chronic lymphocytic leukemia (CLL) by regimen
    Schenkel, Brad
    Ellis, Lorie
    Korrer, Stephanie
    Byfield, Stacey DaCosta
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (07)
  • [23] Demographics, Treatment Patterns, Safety, and Real-World Effectiveness in Patients ≥70 Years of Age with Chronic Lymphocytic Leukemia Receiving Bendamustine with or without Rituximab
    Kolibaba, Kathryn S.
    Joshi, Avani D.
    Sterchele, James A.
    Forsyth, Michael
    Alwon, Erin
    Beygi, Hooman
    Kennealey, Gerard T.
    BLOOD, 2011, 118 (21) : 1674 - 1674
  • [24] Real-world healthcare resource utilization (HRU)/costs associated with venetoclax treatment among chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) patients.
    Rogers, Kerry Anne
    Emond, Bruno
    Manceur, Ameur M.
    Kinkead, Frederic
    Lafeuille, Marie-Helene
    Lefebvre, Patrick
    Huang, Qing
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [25] Real-world comparative effectiveness of acalabrutinib and ibrutinib in patients with chronic lymphocytic leukemia
    Roeker, Lindsey E.
    DerSarkissian, Maral
    Ryan, Kellie
    Chen, Yan
    Duh, Mei Sheng
    Wahlstrom, Svea K.
    Hakre, Shweta
    Yu, Louise
    Guo, Helen
    Mato, Anthony R.
    BLOOD ADVANCES, 2023, 7 (16) : 4291 - 4301
  • [26] Treatment and prognostic testing patterns in patients with chronic lymphocytic leukemia: updates from the informCLL™ real-world registry
    Ghosh, Nilanjan
    Mato, Anthony
    Barrientos, Jacqueline
    Brander, Danielle
    Pagel, John
    Gutierrez, Meghan
    Kadish, Karen
    Tomlinson, Brian
    Upasani, Sandhya
    Sundaram, Murali
    Han, Jennifer
    Amaya-Chanaga, Carlos
    Iyengar, Reethi
    Sharman, Jeff
    LEUKEMIA & LYMPHOMA, 2020, 61 : 31 - 33
  • [27] Real world Effectiveness and safety of Venetoclax in combination with Obinutuzumab in treatment naive CLL patients - Data From the Observational Study VeRVe
    Schwaner, I.
    Hebart, H.
    Losem, C.
    Wolff, T.
    Lehmann, C.
    Benzel, J.
    Huelsenbeck, J.
    Schmidt, B.
    Rossi, D.
    Pichler, P.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 215 - 216
  • [28] Real-World Evidence on Therapeutic Strategies and Treatment-Sequencing in Patients with Chronic Lymphocytic Leukemia: An International Study of Eric, the European Research Initiative on CLL
    Chatzikonstantinou, Thomas
    Scarfo, Lydia
    Demosthenous, Christos
    Kotaskova, Jana
    Iacoboni, Gloria
    Minga, Evangelia
    Chammou, Dimitra
    Karakatsoulis, Georgios
    Albi, Elisa
    Alcoceba, Miguel
    El-Ashwah, Shaimaa
    Bacchiarri, Francesca
    Khan, Mehreen Ali
    Aurran, Therese
    Calleja, Anne
    Cassin, Ramona
    Chatzileontiadou, Sofia
    Christian, Amy
    Claus, Rainer
    Collado, Rosa
    Santos, Marcos Daniel De Deus
    Davis, Zadie
    Dimou, Maria
    Donaldson, David
    Dos Santos, Gimena
    Dreta, Barbara
    Efstathopoulou, Maria
    Enrico, Alicia
    Fresa, Alberto
    Galimberti, Sara
    Garcia-Serra, Rocio
    Gonzalez-Gascon y Marin, Isabel
    Gozzetti, Alessandro
    Guarente, Valerio
    Harrop, Sean
    Hatzimichael, Eleftheria
    Herishanu, Yair
    Inchiappa, Luca
    Iskas, Michalis
    Jaksic, Ozren
    Janssen, Susanne R.
    Kalicinska, Elzbieta
    Karakus, Volkan
    Kater, Arnon P.
    Kho, Bonnie
    Konstantinou, Iliana
    Longval, Thomas
    Koren-Michowitz, Maya
    Kotsianidis, Ioannis
    Kreitman, Robert J.
    BLOOD, 2021, 138
  • [29] Real-World Patient Characteristics, Treatment Patterns, and Outcomes in Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia in China: A Retrospective Analysis Using a Real-World Database
    Liu, Yin
    Chen, Yanfei
    Xiao, Yue
    Huang, Ruijian
    Jiang, Feng
    Yi, Shuhua
    Zhou, Jifang
    BLOOD, 2023, 142
  • [30] Updated Safety and Efficacy Results from a Phase 2 Study of Acalabrutinib, Venetoclax and Obinutuzumab (AVO) for Frontline Treatment of Chronic Lymphocytic Leukemia (CLL)
    Davids, Matthew S.
    Lampson, Benjamin L.
    Tyekucheva, Svitlana
    Crombie, Jennifer L.
    Ng, Samuel
    Kim, Austin I.
    Weinstock, Matthew
    Lowney, Jessica
    Pazienza, Samantha
    Montegaard, Josie
    Patterson, Victoria
    Jacobson, Caron A.
    LaCasce, Ann S.
    Armand, Philippe
    Arnason, Jon E.
    Fisher, David C.
    Brown, Jennifer R.
    BLOOD, 2020, 136
12345